H.R. 8358: Breast Cancer Research Stamp Reauthorization Act of 2026

The bill titled "Breast Cancer Research Stamp Reauthorization Act of 2026" aims to extend the authority of the United States Postal Service (USPS) to issue a specialized postage stamp, known as a semipostal, specifically designed to raise funds for breast cancer research.

Key Provisions

• The primary change proposed by the bill is to amend the existing law that allows the USPS to continue issuing the breast cancer research stamp until 2037, extending its availability by an additional ten years.
• This semipostal stamp is intended to provide a way for the public to contribute to breast cancer research efforts when they purchase the stamp, as a portion of the sale proceeds will be directed towards funding such research.
• The bill was sponsored by a representative, Ms. Van Duyne, along with several co-sponsors from both major political parties, indicating a degree of bipartisan support for the initiative.
• The bill has been referred to multiple committees in the House of Representatives for consideration, which will involve discussions about its provisions and potential impacts before any further action is taken.

Purpose

The primary purpose of this bill is to ensure continued funding for breast cancer research through public support and participation via the purchase of the special postage stamp. By extending the program's authorization, the bill seeks to maintain a source of funding crucial for ongoing research initiatives aimed at combating breast cancer.

Impact of the Bill

By proposing to extend the program, the bill aims to facilitate sustained financial support for breast cancer research, which may include advancements in prevention, treatment, and understanding of the disease. The bill does not allocate government funding but relies instead on the sales of the semipostal stamps to raise money for the cause.

Relevant Companies

None found